Florey Institute for Neuroscience & Mental Health, VIC, Australia.
Florey Institute for Neuroscience & Mental Health, VIC, Australia; Department of Biochemistry and Molecular Biology, University of Melbourne, VIC, Australia.
Mol Cell Endocrinol. 2019 May 1;487:34-39. doi: 10.1016/j.mce.2019.01.008. Epub 2019 Jan 11.
There are seven human relaxin family peptides that have two chains (A and B) and three disulfide bonds. The target receptors for four of these peptides are known as relaxin family peptide receptors, RXFP1-RXFP4. Detailed structure-activity relationship (SAR) studies of relaxin family peptides have been reported over the years and have led to the design of new analogs with agonistic and antagonistic properties. This review briefly summarizes the SAR of human relaxin 2 (H2 relaxin) and human relaxin 3 (H3 relaxin) leading to the design and development of single-B-chain only agonists, B7-33 and peptide 5. The physiological functions of these new peptides agonists in cellular and animal models are also described.
有七种人类松弛素家族肽,它们有两条链(A 和 B)和三个二硫键。其中四种肽的靶受体被称为松弛素家族肽受体,即 RXFP1-RXFP4。多年来,对松弛素家族肽的详细结构-活性关系(SAR)研究已经有报道,并导致具有激动和拮抗特性的新型类似物的设计。本文简要总结了人类松弛素 2(H2 松弛素)和人类松弛素 3(H3 松弛素)的 SAR,从而设计和开发了单 B 链仅激动剂 B7-33 和肽 5。还描述了这些新型肽激动剂在细胞和动物模型中的生理功能。